Lawrence: /* Conclusion */

2025-06-03T21:03:45Z

Conclusion

← Older revision		Revision as of 21:03, 3 June 2025
Line 20:		Line 20:
	'''Limitations'''		'''Limitations'''
	* Does not indicate whether the result is clinically meaningful.		* Does not indicate whether the result is clinically meaningful.
	* Strongly influenced by sample ~~size—small~~ effects can appear statistically significant in large trials and vice versa.		* Strongly influenced by [[sample size]]—small effects can appear statistically significant in large trials and vice versa.

	== 2. Clinical Significance ==		== 2. Clinical Significance ==
Line 29:		Line 29:
	* Focuses on effect size and relevance to patient outcomes, not just p-values.		* Focuses on effect size and relevance to patient outcomes, not just p-values.
	* Often judged using the '''Minimal Clinically Important Difference (MCID)''', the smallest difference patients or clinicians consider beneficial.		* Often judged using the '''Minimal Clinically Important Difference (MCID)''', the smallest difference patients or clinicians consider beneficial.
	* MCID is based on previous literature, expert consensus, or patient-reported outcomes.		* MCID is based on previous literature, expert consensus, or [[patient-reported outcomes]].

	'''Example:'''		'''Example:'''
Line 63:		Line 63:
	* Consider effect size measures (e.g., Cohen’s d, risk difference, odds ratio).		* Consider effect size measures (e.g., Cohen’s d, risk difference, odds ratio).
	* Present confidence intervals to show precision and plausible ranges.		* Present confidence intervals to show precision and plausible ranges.
	* Predefine the MCID in protocols and analysis plans.		* Predefine the MCID in protocols and [[analysis]] plans.

	== Conclusion ==		== Conclusion ==
Line 70:		Line 70:
	* RCTs should prioritize outcomes that are meaningful for patients, not just statistically detectable.		* RCTs should prioritize outcomes that are meaningful for patients, not just statistically detectable.
	* Reporting and interpreting both types of significance supports better decision-making in clinical and policy settings.		* Reporting and interpreting both types of significance supports better decision-making in clinical and policy settings.
			=== Bibliography ===

			# Feinstein AR. The unit of analysis in epidemiology: the fallacy of comparing groups when individuals are the goal. ''American Journal of Epidemiology''. 1985;121(1):1–8.
			# Guyatt GH, Jaeschke R, Heddle N, et al. Basic statistics for clinicians: 2. Interpreting study results: confidence intervals. ''CMAJ''. 1995;152(2):169–173.
			# Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. ''Controlled Clinical Trials''. 1989;10(4 Suppl):407S–415S.
			# Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston: Little, Brown and Company; 1991. Chapter 5: Statistical versus clinical significance.
			# Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. ''Annals of Internal Medicine''. 1999;130(12):1005–1013.

			----
			''Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.''

Lawrence: Created page with "= Clinical significance vs. statistical significance = In Randomized Controlled Trials (RCTs), interpreting results requires understanding both '''statistical significance''' and '''clinical significance'''. While they are related, they address different questions: one about the likelihood of an effect being real, and the other about whether that effect matters in practice. == 1. Statistical Significance == '''Definition:''' Statistical significance tests whether an o..."

2025-03-27T23:08:24Z

Created page with "= Clinical significance vs. statistical significance = In Randomized Controlled Trials (RCTs), interpreting results requires understanding both '''statistical significance''' and '''clinical significance'''. While they are related, they address different questions: one about the likelihood of an effect being real, and the other about whether that effect matters in practice. == 1. Statistical Significance == '''Definition:''' Statistical significance tests whether an o..."

New page

= Clinical significance vs. statistical significance =

In Randomized Controlled Trials (RCTs), interpreting results requires understanding both '''statistical significance''' and '''clinical significance'''. While they are related, they address different questions: one about the likelihood of an effect being real, and the other about whether that effect matters in practice.

== 1. Statistical Significance ==

'''Definition:''' Statistical significance tests whether an observed effect is likely due to chance.

'''Key Features'''
* Determined using p-values and confidence intervals (CIs).
* A p-value < 0.05 is commonly used to denote significance, implying a less than 5% probability that the effect occurred by chance.
* Confidence intervals provide a range of plausible values for the effect; if the CI excludes the null (e.g., 0 for mean difference, 1 for risk ratio), the result is statistically significant.

'''Example:'''
<blockquote>
A new drug reduces systolic blood pressure by 5 mmHg compared to placebo (p = 0.03, 95% CI: 1.2–8.8).
→ Interpretation: The result is statistically significant since p < 0.05 and the CI does not include 0.
</blockquote>

'''Limitations'''
* Does not indicate whether the result is clinically meaningful.
* Strongly influenced by sample size—small effects can appear statistically significant in large trials and vice versa.

== 2. Clinical Significance ==

'''Definition:''' Clinical significance assesses whether an effect is meaningful and beneficial in real-world patient care.

'''Key Features'''
* Focuses on effect size and relevance to patient outcomes, not just p-values.
* Often judged using the '''Minimal Clinically Important Difference (MCID)''', the smallest difference patients or clinicians consider beneficial.
* MCID is based on previous literature, expert consensus, or patient-reported outcomes.

'''Example:'''
<blockquote>
A new drug reduces systolic blood pressure by 5 mmHg, but the MCID is 10 mmHg.
→ Interpretation: The effect is statistically significant but not clinically significant.
</blockquote>

'''Limitations'''
* Involves clinical judgment and may vary by setting, population, or outcome.
* No universally accepted thresholds for all outcomes.

== 3. Comparing Statistical vs. Clinical Significance ==

{| class="wikitable"
|+ '''Comparison of Statistical and Clinical Significance'''
! Aspect !! Statistical Significance !! Clinical Significance
|-
| Definition || Likelihood that an effect is not due to chance || Whether the effect is meaningful for patients
|-
| Measure || p-value, confidence interval || Minimal Clinically Important Difference (MCID)
|-
| Depends on || Sample size, variability || Patient outcomes, clinical judgment
|-
| Limitations || May detect small, unimportant differences || Can be subjective, lacks universal thresholds
|-
| Example || p = 0.02 for a 2 mmHg BP reduction || A 10 mmHg reduction is considered clinically important
|}

== 4. Best Practices in RCTs ==

* Report both statistical and clinical significance for a complete interpretation.
* Consider effect size measures (e.g., Cohen’s d, risk difference, odds ratio).
* Present confidence intervals to show precision and plausible ranges.
* Predefine the MCID in protocols and analysis plans.

== Conclusion ==

* Statistical significance does not imply clinical importance.
* RCTs should prioritize outcomes that are meaningful for patients, not just statistically detectable.
* Reporting and interpreting both types of significance supports better decision-making in clinical and policy settings.

Clinical versus statistical significance - Revision history

Lawrence: /* Conclusion */